PT86783A - Procede de preparation de nouveaux 19-nor steroides substitues en position 7 - Google Patents

Procede de preparation de nouveaux 19-nor steroides substitues en position 7

Info

Publication number
PT86783A
PT86783A PT86783A PT8678388A PT86783A PT 86783 A PT86783 A PT 86783A PT 86783 A PT86783 A PT 86783A PT 8678388 A PT8678388 A PT 8678388A PT 86783 A PT86783 A PT 86783A
Authority
PT
Portugal
Prior art keywords
group
carbon atoms
steroids
hydrogen
optionally substituted
Prior art date
Application number
PT86783A
Other languages
English (en)
Other versions
PT86783B (pt
Inventor
Francois Nique
Lucien Nedelec
Marie-Madeleine Bouton
Daniel Philibert
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of PT86783A publication Critical patent/PT86783A/pt
Publication of PT86783B publication Critical patent/PT86783B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
PT86783A 1987-02-18 1988-02-18 Processo para a preparacao de novos 19-nor esteroides substituidos na posicao na posicao PT86783B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8702072A FR2610933B1 (fr) 1987-02-18 1987-02-18 Nouveaux 19-nor steroides substitues en position 7, leur preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
PT86783A true PT86783A (pt) 1988-03-01
PT86783B PT86783B (pt) 1992-05-29

Family

ID=9348042

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86783A PT86783B (pt) 1987-02-18 1988-02-18 Processo para a preparacao de novos 19-nor esteroides substituidos na posicao na posicao

Country Status (15)

Country Link
US (1) US4874754A (pt)
EP (1) EP0280618B1 (pt)
JP (1) JP2717792B2 (pt)
KR (1) KR960007868B1 (pt)
AT (1) ATE81133T1 (pt)
AU (1) AU610560B2 (pt)
CA (1) CA1313653C (pt)
DE (1) DE3874909T2 (pt)
ES (1) ES2043862T3 (pt)
FI (1) FI92589C (pt)
FR (1) FR2610933B1 (pt)
GR (1) GR3006139T3 (pt)
MX (1) MX174129B (pt)
PT (1) PT86783B (pt)
ZA (1) ZA881030B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212835B (it) * 1983-08-18 1989-11-30 Lehner Ag Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
HU208150B (en) * 1988-10-31 1993-08-30 Endorecherche Inc Process for producing new estrogen derivatives having steroid hormone inhibitor activity and pharmaceutical compositions comprising such derivatives
US5204337A (en) * 1988-10-31 1993-04-20 Endorecherche Inc. Estrogen nucleus derivatives for use in inhibition of sex steroid activity
US5686465A (en) * 1988-10-31 1997-11-11 Endorecherche Inc. Sex steroid activity inhibitors
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
DE69519368T2 (de) * 1994-01-06 2001-03-08 Stanford Res Inst Int Neue antiandrogenen mitteln pharmazeutische präparate und verwendungen davon
CA2308773A1 (en) * 1997-10-23 1999-04-29 Ivo Jirkovsky Estra-1,3,5(10)-triene-7alpha-thioethers
US6355630B1 (en) 1997-10-23 2002-03-12 American Home Products Corporation Estra-1,3,5(10)-triene-7α-thioethers
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) * 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
EP1490390A2 (en) * 2002-03-22 2004-12-29 Pharmacia Corporation C-17 spirolactonization and 6,7 oxidation of steroids
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
PL356465A1 (en) * 2002-10-04 2004-04-05 ANPHARM Przedsiębiorstwo Farmaceutyczne S.A. METHOD OF MANUFACTURE OF 17beta-HYDROXY-7alpha-METHYL-19-NOR-17alpha-PREGN-5(10)-ENE-20-YNE-3-ONE
CA2813433C (en) 2010-10-27 2019-08-20 Dignity Health Trimegestone (tmg) for treatment of preterm birth

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739974A (en) 1953-04-06 1956-03-27 Searle & Co Process of preparing delta4,6-3-ketosteroids
US3099664A (en) 1959-01-12 1963-07-30 Syntex Corp 7-cyano androstane compounds
US3673225A (en) * 1970-01-16 1972-06-27 Organon New 7-alkyl-steroids
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
DE3427795A1 (de) * 1984-07-25 1986-02-06 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 17(alpha)-halogenvinyl-estran-derivate, ihre herstellung und verwendung in der medizin

Also Published As

Publication number Publication date
MX174129B (es) 1994-04-22
KR960007868B1 (ko) 1996-06-13
US4874754A (en) 1989-10-17
EP0280618A1 (fr) 1988-08-31
MX10471A (es) 1993-09-01
FR2610933A1 (fr) 1988-08-19
ZA881030B (en) 1989-04-26
ES2043862T3 (es) 1994-01-01
DE3874909D1 (de) 1992-11-05
FI880742A0 (fi) 1988-02-17
FR2610933B1 (fr) 1989-06-09
CA1313653C (fr) 1993-02-16
PT86783B (pt) 1992-05-29
GR3006139T3 (pt) 1993-06-21
FI92589B (fi) 1994-08-31
KR880009987A (ko) 1988-10-06
AU610560B2 (en) 1991-05-23
FI92589C (fi) 1994-12-12
JP2717792B2 (ja) 1998-02-25
JPS63222198A (ja) 1988-09-16
AU1178588A (en) 1988-08-25
EP0280618B1 (fr) 1992-09-30
DE3874909T2 (de) 1993-05-13
FI880742A (fi) 1988-08-19
ATE81133T1 (de) 1992-10-15

Similar Documents

Publication Publication Date Title
PT86783A (pt) Procede de preparation de nouveaux 19-nor steroides substitues en position 7
DE3650265T2 (de) Makrolide Antibiotika und Verfahren zu deren Herstellung.
KR860005832A (ko) 위치 10에 치환된 스테로이드의 제조방법
ES8104321A1 (es) Procedimiento para separar un derivado de alquil-cetohexopi-ranosida
AU527592B2 (en) 3,20-dioxo-4,9-diene-21-hydroxyl steroid derivatives
NZ231295A (en) Substituted alpha,omega-aminoalcohols and process for the preparation thereof
KR890009901A (ko) 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용
UA13378A (uk) СПОСІБ ОДЕРЖАHHЯ ПОХІДHИХ 14, 17-beta-ЕТАHО-14-beta-ЕСТРАТРІЄHУ
KR850008491A (ko) 신규 세팔로스포린의 제조방법
AU559732B2 (en) Di-and-tetrahydroguinolylacetic acid esters
KR850000454A (ko) 세팔로스포린 유도체의 제조방법
SE8302452D0 (sv) Method for treatment of senile dementia
DE3484089D1 (de) Verfahren zur herstellung von estran-derivaten.
ES2037871T3 (es) Procedimiento para preparar 1-metil-androsta-1,4-dieno-3,17-diona y los nuevos productos intermedios para este procedimiento.
ES459705A1 (es) Procedimiento para la preparacion de derivados de hidracina-piridacina.
IE780933L (en) Pregnene derivatives
KR910002829A (ko) 폴리알킬-2-알콕시-7-히드록시크로만 유도체의 제조방법
MX9100686A (es) Procedimiento para la produccion de 4-pregneno-3,20-dion y productos derivados
ES2071832T3 (es) Procedimiento para la preparacion de derivados de 21-bromo-4-pregneno-3,20-diona.
JPS5441849A (en) Novel cyclopentane derivative
KR890001527A (ko) 에이즈 및 에이즈 관련 복합증상의 억제를 위한 아바콘, 아바롤 및 그 유도체의 용도
ES2070925T3 (es) Procedimiento para la preparacion de 14beta-hidroxi-esteroides.
FI943596A (fi) Menetelmä terapeuttisesti käytt¦kelpoisten makrolidiyhdisteiden valmistamiseksi
DE59204299D1 (de) 14Alpha,17alpha-(Propano- und 17,2-Propeno)-estratriene.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911125

PC3A Transfer or assignment

Free format text: 19991011 HOECHST MARION ROUSSEL FR

PD3A Change of proprietorship

Owner name: ROUSSEL UCLAF

Effective date: 19991011

TE3A Change of address (patent)

Owner name: ROUSSEL UCLAF

Effective date: 19991011

PC3A Transfer or assignment

Free format text: AVENTIS PHARMA S.A. FR

Effective date: 20030110

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040531